Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 17, 2013, Pages 6829-6834

  Wei, Yuanyan ^a   Jiang, Yizhou ^a   Liu, Ying ^a   Zou, Fei ^a   Liu, Ying Chao ^b   Wang, Shanshan ^a   Xu, Nuo ^a   Xu, Wenlong ^c   Cui, Chunhong ^a   Xing, Yang ^a   Cao, Benjin ^a   Liu, Chanjuan ^a   Wu, Guoqiang ^a   Ao, Hong ^c   Zhang, Xiaobiao ^c   Jiang, Jianhai ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GRADING; CANCER STEM CELL; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; GENE SILENCING; GLIOMA; HISTOPATHOLOGY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; GLIOMA; GLYCOPROTEINS; HUMANS; IMMUNOPRECIPITATION; MICE; MICE, INBRED NOD; MICE, SCID; MUTATION, MISSENSE; NEOPLASTIC STEM CELLS; PEPTIDES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84876844907     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1217002110     Document Type: Article

References (47)

1. Lobo NA, Shimono Y, Qian D, Clarke MF (2007) The biology of cancer stem cells. Annu Rev Cell Dev Biol 23:675-699.
2. Dirks PB (2008) Brain tumour stem cells: The undercurrents of human brain cancer and their relationship to neural stem cells. Philos Trans R Soc Lond B Biol Sci 363(1489): 139-152.
3. Yin AH, et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90(12):5002-5012.
4. Miraglia S, et al. (1997) A novel five-transmembrane hematopoietic stem cell antigen: Isolation, characterization, and molecular cloning. Blood 90(12):5013-5021.
5. Hermann PC, et al. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1(3): 313-323.
6. Singh SK, et al. (2004) Identification of human brain tumour initiating cells. Nature 432(7015):396-401.
7. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123):106-110.
8. Ricci-Vitiani L, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445(7123):111-115.
9. Ma S, et al. (2007) Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132(7):2542-2556.
10. Beier D, et al. (2007) CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67(9): 4010-4015.
11. Joo KM, et al. (2008) Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 88(8):808-815.
12. Wang J, et al. (2008) CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122(4):761-768.
13. Bidlingmaier S, Zhu X, Liu B (2008) The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med (Berl) 86(9):1025-1032.
14. Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY (2008) CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 27(12):1749-1758.
15. Sartelet H, et al. (2012) CD133 expression is associated with poor outcome in neu-roblastoma via chemoresistance mediated by the AKT pathway. Histopathology 60(7): 1144-1155.
16. Wang YK, et al. (2010) Activation of Akt and MAPK pathways enhances the tumor-igenicity of CD133+ primary colon cancer cells. Carcinogenesis 31(8):1376-1380.
17. Holland EC, et al. (2000) Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25(1):55-57.
18. Uhrbom L, et al. (2002) Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res 62(19):5551-5558.
19. Hambardzumyan D, Squatrito M, Carbajal E, Holland EC (2008) Glioma formation, cancer stem cells, and akt signaling. Stem Cell Rev 4(3):203-210.
20. Hambardzumyan D, et al. (2008) PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev 22(4):436-448.
21. Eyler CE, et al. (2008) Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells 26(12):3027-3036.
22. Manning BD, Cantley LC (2007) AKT/PKB signaling: Navigating downstream. Cell 129(7):1261-1274.
23. Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2(7):489-501.
24. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216): 1061-1068.
25. Parsons DW, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807-1812.
26. Jaiswal BS, et al. (2009) Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation. Cancer Cell 16(6):463-474.
27. Stokoe D, et al. (1997) Dual role of phosphatidylinositol-3, 4, 5-trisphosphate in the activation of protein kinase B. Science 277(5325):567-570.
28. Alessi DR, et al. (1997) Characterization of a 3-phosphoinositide- dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7(4): 261-269.
29. Hirsch E, Costa C, Ciraolo E (2007) Phosphoinositide 3-kinases as a common platform for multi-hormone signaling. J Endocrinol 194(2):243-256.
30. Boivin D, et al. (2009) The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases. Biochemistry 48(18):3998-4007.
31. Songyang Z, et al. (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72(5):767-778.
32. Kontos CD, et al. (1998) Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 18(7):4131-4140.
33. Ponzetto C, et al. (1993) A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor. Mol Cell Biol 13(8):4600-4608.
34. Du J, et al. (2009) Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy. Nat Biotechnol 27(1):77-83.
35. Lu KV, et al. (2009) Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. Cancer Res 69(17):6889-6898.
36. Röper K, Corbeil D, Huttner WB (2000) Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol 2(9):582-592.
37. Corbeil D, et al. (2000) The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 275(8):5512-5520.
38. Weigmann A, Corbeil D, Hellwig A, Huttner WB (1997) Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci USA 94(23):12425-12430.
39. Lee MY, Ryu JM, Lee SH, Park JH, Han HJ (2010) Lipid rafts play an important role for maintenance of embryonic stem cell self-renewal. J Lipid Res 51(8):2082-2089.
40. Yamazaki S, et al. (2006) Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J 25(15):3515-3523.
41. Corbeil D, Röper K, Hannah MJ, Hellwig A, Huttner WB (1999) Selective localization of the polytopic membrane protein prominin in microvilli of epithelial cells-a combination of apical sorting and retention in plasma membrane protrusions. J Cell Sci 112(Pt 7):1023-1033.
42. Summy JM, Gallick GE (2006) Treatment for advanced tumors: SRC reclaims center stage. Clin Cancer Res 12(5):1398-1401.
43. Yeatman TJ (2004) A renaissance for SRC. Nat Rev Cancer 4(6):470-480.
44. Christensen K, Schrøder HD, Kristensen BW (2008) CD133 identifies perivascular niches in grade II-IV astrocytomas. J Neurooncol 90(2):157-170.
45. Bao S, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756-760.
46. Popa-Nita O, et al. (2007) Crystal-induced neutrophil activation. IX. Syk-dependent activation of class Ia phosphatidylinositol 3-kinase. J Leukoc Biol 82(3):763-773.
47. Yuan HT, Khankin EV, Karumanchi SA, Parikh SM (2009) Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 29(8): 2011-2022.